SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-21-000441
Filing Date
2021-05-14
Accepted
2021-05-14 16:07:59
Documents
2
Period of Report
2021-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k051421_8k.htm 8-K 18716
2 EXHIBIT 10.1 EQUITY PURCHASE AGREEMENT, DATED MAY 14, 2021, BY AND BETWEEN THE C f8k051421_ex10z1.htm EX-10.1 120138
  Complete submission text file 0001078782-21-000441.txt   140104
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 21924609
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences